Gibbons C, Wang N, Rajan S, Kern D, Palma J, Kaufmann H
Neurology. 2023; 100(15):e1529-e1539.
PMID: 36657992
PMC: 10103107.
DOI: 10.1212/WNL.0000000000206772.
David F, Rivera Y, Entezar T, Arora R, Drane Q, Munoz M
Front Neurol. 2022; 13:980935.
PMID: 36324383
PMC: 9618698.
DOI: 10.3389/fneur.2022.980935.
Gibbons C, Freeman R, Bellaire B, Adler C, Moore D, Levine T
Biomark Med. 2022; 16(7):499-509.
PMID: 35272481
PMC: 9169016.
DOI: 10.2217/bmm-2021-0646.
Mollaei F, Shiller D, Baum S, Gracco V
Sci Rep. 2022; 12(1):1019.
PMID: 35046514
PMC: 8770631.
DOI: 10.1038/s41598-022-05128-8.
Santos-Garcia D, de Deus T, Cores C, Canfield H, Paz Gonzalez J, Martinez Miro C
J Pers Med. 2021; 11(7).
PMID: 34209166
PMC: 8305732.
DOI: 10.3390/jpm11070626.
Measuring freezing of gait during daily-life: an open-source, wearable sensors approach.
Mancini M, Shah V, Stuart S, Curtze C, Horak F, Safarpour D
J Neuroeng Rehabil. 2021; 18(1):1.
PMID: 33397401
PMC: 7784003.
DOI: 10.1186/s12984-020-00774-3.
Automated Hippocampal Subfield Volumetric Analyses in Atypical Alzheimer's Disease.
Gabere M, Pham N, Graff-Radford J, Machulda M, Duffy J, Josephs K
J Alzheimers Dis. 2020; 78(3):927-937.
PMID: 33074228
PMC: 7732352.
DOI: 10.3233/JAD-200625.
Phosphorylated Alpha-Synuclein Within Cutaneous Autonomic Nerves of Patients With Parkinson's Disease: The Implications of Sample Thickness on Results.
Wang N, Garcia J, Freeman R, Gibbons C
J Histochem Cytochem. 2020; 68(10):669-678.
PMID: 32921251
PMC: 7534099.
DOI: 10.1369/0022155420960250.
Isradipine Versus Placebo in Early Parkinson Disease: A Randomized Trial.
Ann Intern Med. 2020; 172(9):591-598.
PMID: 32227247
PMC: 7465126.
DOI: 10.7326/M19-2534.
Executive Function Is Related to the Urinary Urgency in Non-demented Patients With Parkinson's Disease.
Tkaczynska Z, Becker S, Maetzler W, Timmers M, van Nueten L, Sulzer P
Front Aging Neurosci. 2020; 12:55.
PMID: 32210789
PMC: 7069351.
DOI: 10.3389/fnagi.2020.00055.
Circulating cell-free mitochondrial DNA levels in Parkinson's disease are influenced by treatment.
Lowes H, Pyle A, Santibanez-Koref M, Hudson G
Mol Neurodegener. 2020; 15(1):10.
PMID: 32070373
PMC: 7029508.
DOI: 10.1186/s13024-020-00362-y.
Time Perception of an Artwork's Manipulation Is Distorted by Patients With Parkinson's Disease.
Motta M, Tumas V, Bueno J
Front Integr Neurosci. 2019; 13:6.
PMID: 30906255
PMC: 6419149.
DOI: 10.3389/fnint.2019.00006.
The Diagnostic Scope of Sensor-Based Gait Analysis in Atypical Parkinsonism: Further Observations.
Gassner H, Raccagni C, Eskofier B, Klucken J, Wenning G
Front Neurol. 2019; 10:5.
PMID: 30723450
PMC: 6349719.
DOI: 10.3389/fneur.2019.00005.
The Impact Of Freezing Of Gait On Balance Perception And Mobility In Community-Living With Parkinson'S Disease.
Mancini M, Curtze C, Stuart S, El-Gohary M, James , McNames
Annu Int Conf IEEE Eng Med Biol Soc. 2018; 2018:3040-3043.
PMID: 30441036
PMC: 7765340.
DOI: 10.1109/EMBC.2018.8512910.
Effects of Tyrosine on Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.
DiFrancisco-Donoghue J, Rabin E, Lamberg E, Werner W
Mov Disord Clin Pract. 2018; 1(4):348-353.
PMID: 30363894
PMC: 6183247.
DOI: 10.1002/mdc3.12082.
Sensor-based gait analysis in atypical parkinsonian disorders.
Raccagni C, Gassner H, Eschlboeck S, Boesch S, Krismer F, Seppi K
Brain Behav. 2018; 8(6):e00977.
PMID: 29733529
PMC: 5991583.
DOI: 10.1002/brb3.977.
Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort.
Simuni T, Caspell-Garcia C, Coffey C, Weintraub D, Mollenhauer B, Lasch S
J Neurol Neurosurg Psychiatry. 2017; 89(1):78-88.
PMID: 28986467
PMC: 5732865.
DOI: 10.1136/jnnp-2017-316213.
Impact of disease duration and cardiovascular dysautonomia on hypertension in Parkinson's disease.
Vetrano D, Pisciotta M, Brandi V, Lo Monaco M, Laudisio A, Onder G
J Clin Hypertens (Greenwich). 2016; 19(4):418-423.
PMID: 27804276
PMC: 8031361.
DOI: 10.1111/jch.12938.
Predictors of time to initiation of symptomatic therapy in early Parkinson's disease.
Simuni T, Long J, Caspell-Garcia C, Coffey C, Lasch S, Tanner C
Ann Clin Transl Neurol. 2016; 3(7):482-94.
PMID: 27386498
PMC: 4931714.
DOI: 10.1002/acn3.317.
Assessing of plasma levels of iron, zinc and copper in Iranian Parkinson's disease.
Meamar R, Nikyar H, Dehghani L, Basiri K, Aghaye Ghazvini M
Adv Biomed Res. 2016; 5:31.
PMID: 27099844
PMC: 4815529.
DOI: 10.4103/2277-9175.178788.
